WORLDLINE SA (WLN.PA) 37.53 +0.34 (+0.91%)
37.53 +0.34 (+0.91%)
FR0011981968 - Common Stock
Fundamental Rating
We assign a fundamental rating of 2 out of 10 to WLN. WLN was compared to 0 industry peers in the Unkown industry. WLN has a bad profitability rating. Also its financial health evaluation is rather negative. While showing a medium growth rate, WLN is valued expensive at the moment.
Note: WLN has only limited data available, so a full analysis was not possible, which makes the total rating unfair.
Profitability
Profitability Rating
The Piotroski-F score of WLN is 3.00. This is a low score and indicates issues in the health and profitability of WLN.
VS Industry
Valuation
Valuation Rating
With a Forward Price/Earnings Ratio of 15.02, WLN is valued correctly.
When comparing the current price to the book value of WLN, we can conclude it is valued correctly. It is trading at 1.14 times its book value.
The Price/Earnings Ratio is negative for WLN. In the last year negative earnings were reported.
The high PEG Ratio, which compensates the Price/Earnings for growth, indicates WLN does not grow enough to justify the current Price/Earnings ratio.
VS Industry
Growth
Growth Rating
Based on estimates for the next 5 years, WLN will show a quite strong growth in Earnings Per Share. The EPS will grow by 13.07% on average per year.
WLN shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 12.05%.
WLN shows a strong growth in Revenue. Measured over the last 5 years, the Revenue has been growing by 23.02% yearly.
Based on estimates for the next 5 years, WLN will show a small growth in Revenue. The Revenue will grow by 8.74% on average per year.
The earnings per share for WLN have decreased strongly by -576.12% in the last year.
The Revenue growth is decreasing: in the next 5 years the growth will be less than in the last years.
| Past | Future | ||||||
|---|---|---|---|---|---|---|---|
| 5Y | 3Y | 1Y | 1Y | 2Y | 3Y | 5Y | |
| EPS | N/A | N/A | -576.12% | 4.67% | 9.18% | 12.32% | 13.07% |
| Revenue | 23.02% | 28.96% | 12.05% | 6.36% | 8.22% | 8.62% | 8.74% |
Health
Health Rating
WLN has a Current Ratio of 0.88. This is a bad value and indicates that WLN is not financially healthy enough and could expect problems in meeting its short term obligations.
A Quick Ratio of 0.87 indicates that WLN may have some problems paying its short term obligations.
Based on the Altman-Z score of 0.65, we must say that WLN is in the distress zone and has some risk of bankruptcy.
WLN has a quite weak Piotroski-F score of 3.00. This indicates issues in the health and profitability of WLN.
VS Industry
Dividend
Dividend Rating
WLN does not give a dividend.
WORLDLINE SA37.53
EPA:WLN (3/29/2023, 9:53:03 AM)+0.34 (+0.91%)
Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap10.55B
Analysts78.33
Price Target54.82 (46.07%)
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)N/A
DP0.99%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)18.57%
Min EPS beat(2)18.57%
Max EPS beat(2)18.57%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
Revenue beat(2)1
Avg Revenue beat(2)1.6%
Min Revenue beat(2)1.6%
Max Revenue beat(2)1.6%
Revenue beat(4)1
Avg Revenue beat(4)-16.51%
Min Revenue beat(4)-34.61%
Max Revenue beat(4)1.6%
PT rev (1m)-0.03%
PT rev (3m)-0.85%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)2.61%
EPS NY rev (3m)2.61%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.11%
Revenue NY rev (3m)-0.11%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 15.02 | ||
| P/S | 3.07 | ||
| P/FCF | 14.89 | ||
| P/OCF | 10.64 | ||
| P/B | 1.14 | ||
| P/tB | N/A | ||
| EV/EBITDA | 14.82 |
EPS(TTM)-3.19
EYN/A
EPS(NY)2.5
Fwd EY6.66%
FCF(TTM)2.52
FCFY6.72%
OCF(TTM)3.53
OCFY9.4%
SpS12.23
BVpS32.92
TBVpS-12.29
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | N/A | ||
| ROE | N/A | ||
| ROIC | 2.05% | ||
| ROICexc | 2.41% | ||
| ROICexgc | 46.77% | ||
| OM | 12.49% | ||
| PM | N/A | ||
| GM | 90.5% |
ROICexgc(3y)N/A
ROICexcg growth 3Y-66.55%
ROICexcg growth 5Y-54.56%
ROICexc(3y)3.31%
ROICexc growth 3Y-21.04%
ROICexc growth 5Y-32.27%
OM growth 3Y-7.54%
OM growth 5Y-8.1%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.05%
GM growth 5Y-1.43%
F-Score3
Asset Turnover0.15
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.37 | ||
| Debt/FCF | 7.13 | ||
| Debt/EBITDA | 5.75 | ||
| Cap/Depr | 62.99% | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.88 | ||
| Quick Ratio | 0.87 | ||
| Altman-Z | 0.65 |
F-Score3
WACC6.12%
ROIC/WACC7.64
Cap/Depr(3y)52.72%
Cap/Depr(5y)70.31%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
Growth
EPS 1Y-576.12%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-144.12%
EPS Next Y4.67%
EPS Next 2Y9.18%
EPS Next 3Y12.32%
EPS Next 5Y13.07%
Revenue growth 1Y12.05%
Revenue growth 3Y28.96%
Revenue growth 5Y23.02%
Revenue growth Q2Q19.25%
Revenue Next Year6.36%
Revenue Next 2Y8.22%
Revenue Next 3Y8.62%
Revenue Next 5Y8.74%
EBIT growth 1Y24.48%
EBIT growth 3Y19.24%
EBIT growth 5Y13.06%
EBIT Next Year91.98%
EBIT Next 3Y35.56%
EBIT Next 5Y25.29%
FCF growth 1Y124.1%
FCF growth 3Y53.82%
FCF growth 5Y40.5%
OCF growth 1Y121.38%
OCF growth 3Y46.33%
OCF growth 5Y34.46%
Fundamental Stock Screener Links
Fundamental Stock Screener
Find stocks with similar Fundamental rating on the EuroNext